Sign in
Explore the registryTrack Neoadjuvant olaparib monotherapy group's trials

OlympiaN

Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer

Neoadjuvant Olaparib monotherapy groupOngoingActive not recruitingPhase 2Open NCT05498155 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…